| Neutralization of tumor necrosis factor-related apoptosis-inducing ligand reduces spinal cord injury damage in mice. | |
| | |
MedLine Citation:
|
PMID: 20107429 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Spinal cord injury (SCI) is a major cause of disability, its clinical outcome depending mostly on the extent of damage in which proapoptotic cytokines have a crucial function. In particular, the inducers of apoptosis belonging to TNF receptor superfamily and their respective ligands are upregulated after SCI. In this study, the function of the proapoptotic cytokine tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in SCI-induced damage was investigated in the mouse. SCI resulted in severe trauma, characterized by prominent inflammation-related damage and apoptosis. Immunostaining for TRAIL and its receptor DR5 was found in the white and gray matter of the perilesional area, as also confirmed by western blotting experiments. Immunoneutralization of TRAIL resulted in improved functional recovery, reduced apoptotic cell number, modulation of molecules involved in the inflammatory response (FasL, TNF-alpha, IL-1beta, and MPO), and the corresponding signaling (caspase-8 and -3 activation, JNK phosphorylation, Bax, and Bcl-2 expression). As glucocorticoid-induced TNF receptor superfamily-related protein (GITR) activated by its ligand (GITRL) contributes to SCI-related inflammation, interactions between TRAIL and GITRL were investigated. SCI was associated with upregulated GITR and GITRL expression, a phenomenon prevented by anti-TRAIL treatment. Moreover, the expression of both TRAIL and DR5 was reduced in tissues from mice lacking the GITR gene (GITR(-/-)) in comparison with wild-type mice suggesting that TRAIL- and GITRL-activated pathways synergise in the development of SCI-related inflammatory damage. Characterization of new targets within such molecular systems may constitute a platform for innovative treatment of SCI. |
| | |
Authors:
|
Giuseppina Cantarella; Giulia Di Benedetto; Mimmo Scollo; Irene Paterniti; Salvatore Cuzzocrea; Paolo Bosco; Giuseppe Nocentini; Carlo Riccardi; Renato Bernardini |
Related Documents
:
|
19481529 - Akt and 14-3-3 control a pacs-2 homeostatic switch that integrates membrane traffic wit... 11212279 - Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apopto... 15356269 - Differential regulation of the trail death receptors dr4 and dr5 by the signal recognit... 12748989 - Carpobrotus edulis methanol extract inhibits the mdr efflux pumps, enhances killing of ... 18298899 - Beta-sitosterol sensitizes mda-mb-231 cells to trail-induced apoptosis. 16003319 - Regulation of the resistance to trail-induced apoptosis as a new strategy for pancreati... 19286259 - The role of the activating receptor nkg2d in autoimmunity. 7057139 - Murine serum glycoprotein gp70 behaves as an acute phase reactant. 2688809 - Growth factors in embryogenesis. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2010-01-27 |
Journal Detail:
|
Title: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology Volume: 35 ISSN: 1740-634X ISO Abbreviation: Neuropsychopharmacology Publication Date: 2010 May |
Date Detail:
|
Created Date: 2010-04-16 Completed Date: 2010-07-12 Revised Date: 2011-07-28 |
Medline Journal Info:
|
Nlm Unique ID: 8904907 Medline TA: Neuropsychopharmacology Country: United States |
Other Details:
|
Languages: eng Pagination: 1302-14 Citation Subset: IM |
Affiliation:
|
Department of Experimental and Clinical Pharmacology, University of Catania School of Medicine, Catania, Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Antibodies, Neutralizing / pharmacology*, therapeutic use Apoptosis / drug effects, physiology Apoptosis Regulatory Proteins / metabolism Disease Models, Animal Inflammation / drug therapy, metabolism, physiopathology Inflammation Mediators / metabolism Male Mice Mice, Knockout Receptors, TNF-Related Apoptosis-Inducing Ligand / drug effects, metabolism Spinal Cord Injuries / drug therapy*, metabolism, physiopathology TNF-Related Apoptosis-Inducing Ligand / antagonists & inhibitors*, immunology, metabolism Tumor Necrosis Factors / genetics* |
| Chemical | |
Reg. No./Substance:
|
0/Antibodies, Neutralizing; 0/Apoptosis Regulatory Proteins; 0/Inflammation Mediators; 0/Receptors, TNF-Related Apoptosis-Inducing Ligand; 0/TNF-Related Apoptosis-Inducing Ligand; 0/Tnfsf10 protein, mouse; 0/Tnfsf18 protein, mouse; 0/Tumor Necrosis Factors |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Standard Kt/V(urea): a method of calculation that includes effects of fluid removal and residual kid...
Next Document: A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-ind...